Showing results (91-100 of 128) with videos related to
Sort By:
Pageof 13
Oncoimmunology|June 27, 2013
The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysatesSerena Pellegatta, Marica Eoli, Simona Frigerio, et al.Cancer Research|June 29, 2012
The MET oncogene is a functional marker of a glioblastoma stem cell subtypeFrancesca De Bacco, Elena Casanova, Enzo Medico, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristicsPiergiorgio Modena, Elena Lualdi, Federica Facchinetti, et al.Cell Reports|July 28, 2021
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastomaFrancesca De Bacco, Francesca Orzan, Jessica Erriquez, et al.EMBO Molecular Medicine|May 4, 2016
MET inhibition overcomes radiation resistance of glioblastoma stem-like cellsFrancesca De Bacco, Antonio D'Ambrosio, Elena Casanova, et al.Ebiomedicine|August 31, 2019
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheresDean Nehama, Natalia Di Ianni, Silvia Musio, et al.Cancer Immunology Research|February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic SignalingElisa Landoni, Giovanni Fucá, Jian Wang, et al.Journal of the National Cancer Institute|March 6, 2015
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomideManuela Cominelli, Salvatore Grisanti, Stefania Mazzoleni, et al.Neuro-Oncology|March 15, 2006
Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1Tiziana Piepoli, Cemile Jakupoglu, Wenli Gu, et al.Oncoimmunology|April 11, 2018
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomideSerena Pellegatta, Marica Eoli, Valeria Cuccarini, et al.Pageof 13